Skip to main content
. 2016 Jan 14;7(1):e2058. doi: 10.1038/cddis.2015.275

Table 4. Clinical studies of BH3 mimetic as anticancer drugs.

Agents Nature of the agent Disease type Phase Reference
Obatoclax BH3 mimetic SCLC and myelofibrosis I 139, 140
Gossypol BH3 mimetic Metastic breast cancer and CRPC I and II 141, 142, 143
ABT-263 BH3 mimetic Advanced haematological cancers I 144
ABT-199 BH3 mimetic CLL I 145

Abbreviations: SCLC, small-cell lung cancer; CRPC, castration-resistant prostate cancer; CLL, chronic lymphocytic leukaemia